Core Laboratories Inc. (NYSE:CLB) Plans Quarterly Dividend of $0.01

Core Laboratories Inc. (NYSE:CLB - Get Free Report) announced a quarterly dividend on Wednesday, January 29th,Wall Street Journal reports. Investors of record on Monday, February 10th will be paid a dividend of 0.01 per share by the oil and gas company on Monday, March 3rd. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. The ex-dividend date of this dividend is Monday, February 10th.

Core Laboratories has increased its dividend by an average of 10.1% per year over the last three years. Core Laboratories has a payout ratio of 3.5% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Core Laboratories to earn $1.11 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 3.6%.

Core Laboratories Stock Down 2.3 %

Shares of Core Laboratories stock traded down $0.39 during trading on Monday, hitting $16.58. 319,226 shares of the stock traded hands, compared to its average volume of 300,544. Core Laboratories has a 52-week low of $13.82 and a 52-week high of $25.13. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The firm has a market cap of $778.29 million, a P/E ratio of 25.12, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. The stock's fifty day simple moving average is $18.76 and its 200 day simple moving average is $19.32.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting the consensus estimate of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. On average, equities analysts predict that Core Laboratories will post 0.96 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CLB. StockNews.com upgraded Core Laboratories from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Citigroup decreased their target price on Core Laboratories from $15.00 to $14.00 and set a "sell" rating on the stock in a research report on Thursday, October 31st. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $17.00.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.